Table 3.
Signalment of diabetic cats and pretreatment with antidiabetic medications before inclusion in the study
| Animals | Exenatide ER (n = 15) | Placebo (n = 15) | P‐value |
|---|---|---|---|
| Age in years | |||
| Median (range) | 9.3 (4.3–14.0) | 10 (2.6–15.0) | .468 |
| Mean (SD) | 9.0 (3.2) | 9.8 (3.7) | |
| Body weight in kg | |||
| Median (range) | 5.3 (4.4–7.4) | 4.5 (2.7–8.3) | .110 |
| Mean (SD) | 5.5 (1.0) | 4.9 (1.5) | |
| Domestic short‐ or longhair | 12 (80%) | 14 (93.3%) | .598 |
| Purebred | 3 (20%) | 1 (6.7%) | |
| Neutered male | 9 (60%) | 5 (33.3%) | .143 |
| Intact male | 1 (6.7%) | 0 (0%) | |
| Spayed female | 5 (33.3%) | 10 (66.7%) | |
| Pretreatmenta | 8 (53.3%) | 10 (66.7%) | .710 |
SD, standard deviation.
a
Antidiabetic medications received before inclusion.